RecruitingNot ApplicableNCT05447923

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

Colorectal Cancer Screening in Black and Underserved Communities in the Phoenix Metro Area: Addressing Disparities in Cancer Prevention

Sponsor

Mayo Clinic

Enrollment

450 participants

Start Date

May 22, 2022

Study Type

INTERVENTIONAL

Conditions

Colorectal Carcinoma

Summary

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Eligibility

Min Age: 45 Years

Inclusion Criteria7

Age 45 years of age or older
No prior history of colorectal cancer or colon polyps
No first-degree family history of colorectal cancer who were diagnosed under age 60
No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
Have not undergone a colonoscopy in the last 5 years
Have not had a fecal immunochemical test (FIT) test within the last year
Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area